AU2010315106A1 - Multiple layer filamentary devices or treatment of vascular defects - Google Patents
Multiple layer filamentary devices or treatment of vascular defects Download PDFInfo
- Publication number
- AU2010315106A1 AU2010315106A1 AU2010315106A AU2010315106A AU2010315106A1 AU 2010315106 A1 AU2010315106 A1 AU 2010315106A1 AU 2010315106 A AU2010315106 A AU 2010315106A AU 2010315106 A AU2010315106 A AU 2010315106A AU 2010315106 A1 AU2010315106 A1 AU 2010315106A1
- Authority
- AU
- Australia
- Prior art keywords
- filaments
- permeable shell
- shell
- inner structure
- state
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 160
- 230000007556 vascular defect Effects 0.000 title claims description 112
- 210000005166 vasculature Anatomy 0.000 claims abstract description 137
- 238000000034 method Methods 0.000 claims abstract description 87
- 230000017531 blood circulation Effects 0.000 claims abstract description 29
- 230000001732 thrombotic effect Effects 0.000 claims description 13
- 238000004904 shortening Methods 0.000 claims 1
- 230000002490 cerebral effect Effects 0.000 abstract description 6
- 206010002329 Aneurysm Diseases 0.000 description 166
- UQMRAFJOBWOFNS-UHFFFAOYSA-N butyl 2-(2,4-dichlorophenoxy)acetate Chemical compound CCCCOC(=O)COC1=CC=C(Cl)C=C1Cl UQMRAFJOBWOFNS-UHFFFAOYSA-N 0.000 description 91
- 239000000463 material Substances 0.000 description 67
- 239000011148 porous material Substances 0.000 description 49
- 208000007536 Thrombosis Diseases 0.000 description 37
- 230000002792 vascular Effects 0.000 description 35
- 230000007547 defect Effects 0.000 description 27
- 210000004369 blood Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- 239000007943 implant Substances 0.000 description 22
- 239000000835 fiber Substances 0.000 description 20
- 239000010410 layer Substances 0.000 description 20
- 230000015572 biosynthetic process Effects 0.000 description 19
- 238000000576 coating method Methods 0.000 description 19
- -1 polyethylene Polymers 0.000 description 17
- 229920000642 polymer Polymers 0.000 description 17
- 201000008450 Intracranial aneurysm Diseases 0.000 description 16
- 230000008569 process Effects 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 15
- 210000004204 blood vessel Anatomy 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 230000036961 partial effect Effects 0.000 description 14
- 238000007789 sealing Methods 0.000 description 14
- 229910052751 metal Inorganic materials 0.000 description 13
- 239000002184 metal Substances 0.000 description 13
- 238000009954 braiding Methods 0.000 description 12
- 230000007246 mechanism Effects 0.000 description 11
- 210000001367 artery Anatomy 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 239000011248 coating agent Substances 0.000 description 10
- 230000003073 embolic effect Effects 0.000 description 10
- 229910045601 alloy Inorganic materials 0.000 description 9
- 239000000956 alloy Substances 0.000 description 9
- 230000035602 clotting Effects 0.000 description 9
- 239000004020 conductor Substances 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 239000003550 marker Substances 0.000 description 9
- 210000004556 brain Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000035876 healing Effects 0.000 description 8
- 150000002739 metals Chemical class 0.000 description 8
- 229910001000 nickel titanium Inorganic materials 0.000 description 8
- 230000001154 acute effect Effects 0.000 description 7
- 239000002131 composite material Substances 0.000 description 7
- 238000002513 implantation Methods 0.000 description 7
- 206010053567 Coagulopathies Diseases 0.000 description 6
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 230000010102 embolization Effects 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000009998 heat setting Methods 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 230000002441 reversible effect Effects 0.000 description 6
- 238000004513 sizing Methods 0.000 description 6
- 238000004381 surface treatment Methods 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 238000003466 welding Methods 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 238000005476 soldering Methods 0.000 description 5
- 230000002885 thrombogenetic effect Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 229910003460 diamond Inorganic materials 0.000 description 4
- 239000010432 diamond Substances 0.000 description 4
- 210000001105 femoral artery Anatomy 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 230000001788 irregular Effects 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 3
- 229920000106 Liquid crystal polymer Polymers 0.000 description 3
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 3
- 229920000954 Polyglycolide Polymers 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 238000004026 adhesive bonding Methods 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 238000002583 angiography Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000005056 compaction Methods 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 238000001259 photo etching Methods 0.000 description 3
- 229920001610 polycaprolactone Polymers 0.000 description 3
- 239000004632 polycaprolactone Substances 0.000 description 3
- 239000004626 polylactic acid Substances 0.000 description 3
- 239000004753 textile Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000009941 weaving Methods 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 241000531908 Aramides Species 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 108010007267 Hirudins Proteins 0.000 description 2
- 102000007625 Hirudins Human genes 0.000 description 2
- 229920000271 Kevlar® Polymers 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920001410 Microfiber Polymers 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 229920000265 Polyparaphenylene Polymers 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 206010068149 Vessel perforation Diseases 0.000 description 2
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 2
- 229920006397 acrylic thermoplastic Polymers 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- KXNPVXPOPUZYGB-XYVMCAHJSA-N argatroban Chemical compound OC(=O)[C@H]1C[C@H](C)CCN1C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C1=CC=CC2=C1NC[C@H](C)C2 KXNPVXPOPUZYGB-XYVMCAHJSA-N 0.000 description 2
- 229960003856 argatroban Drugs 0.000 description 2
- 229920003235 aromatic polyamide Polymers 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 239000012867 bioactive agent Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 229960002768 dipyridamole Drugs 0.000 description 2
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 2
- 238000009760 electrical discharge machining Methods 0.000 description 2
- 229960001123 epoprostenol Drugs 0.000 description 2
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 2
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 2
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 2
- 229940006607 hirudin Drugs 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000004761 kevlar Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000003658 microfiber Substances 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920001432 poly(L-lactide) Polymers 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920001692 polycarbonate urethane Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000002321 radial artery Anatomy 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 229910000679 solder Inorganic materials 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- MHSKRLJMQQNJNC-UHFFFAOYSA-N terephthalamide Chemical compound NC(=O)C1=CC=C(C(N)=O)C=C1 MHSKRLJMQQNJNC-UHFFFAOYSA-N 0.000 description 2
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- KAGLWQUWUNBAOO-KSZLIROESA-N (2s)-n-[(2s)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2r)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide Chemical compound C([C@@H](NC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C=O)C1=CC=CC=C1 KAGLWQUWUNBAOO-KSZLIROESA-N 0.000 description 1
- PWINFPFVCZSLBF-RTWAWAEBSA-N (3s)-4-[[(2r)-1-amino-3-cyclohexyl-1-oxopropan-2-yl]amino]-3-[[2-[ethyl(4-piperidin-4-ylbutanoyl)amino]acetyl]amino]-4-oxobutanoic acid Chemical compound C([C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CN(CC)C(=O)CCCC1CCNCC1)C(N)=O)C1CCCCC1 PWINFPFVCZSLBF-RTWAWAEBSA-N 0.000 description 1
- GQGRDYWMOPRROR-ZIFKCHSBSA-N (e)-7-[(1r,2r,3s,5s)-3-hydroxy-5-[(4-phenylphenyl)methoxy]-2-piperidin-1-ylcyclopentyl]hept-4-enoic acid Chemical compound O([C@H]1C[C@@H]([C@@H]([C@H]1CC\C=C\CCC(O)=O)N1CCCCC1)O)CC(C=C1)=CC=C1C1=CC=CC=C1 GQGRDYWMOPRROR-ZIFKCHSBSA-N 0.000 description 1
- PYZOVVQJTLOHDG-FQEVSTJZSA-N 2-[(2s)-4-methyl-3-oxo-7-(4-piperidin-4-ylpiperidine-1-carbonyl)-2,5-dihydro-1h-1,4-benzodiazepin-2-yl]acetic acid Chemical compound O=C([C@H](CC(O)=O)NC1=CC=2)N(C)CC1=CC=2C(=O)N(CC1)CCC1C1CCNCC1 PYZOVVQJTLOHDG-FQEVSTJZSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 1
- 239000005528 B01AC05 - Ticlopidine Substances 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 238000012276 Endovascular treatment Methods 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010056764 Eptifibatide Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 1
- 229920002633 Kraton (polymer) Polymers 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 102000003938 Thromboxane Receptors Human genes 0.000 description 1
- 108090000300 Thromboxane Receptors Proteins 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920000508 Vectran Polymers 0.000 description 1
- 239000004979 Vectran Substances 0.000 description 1
- 229910001080 W alloy Inorganic materials 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 229960000446 abciximab Drugs 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002965 anti-thrombogenic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 239000004019 antithrombin Substances 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000001841 basilar artery Anatomy 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- OIRCOABEOLEUMC-GEJPAHFPSA-N bivalirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 OIRCOABEOLEUMC-GEJPAHFPSA-N 0.000 description 1
- 108010055460 bivalirudin Proteins 0.000 description 1
- 229960001500 bivalirudin Drugs 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 210000002302 brachial artery Anatomy 0.000 description 1
- 238000005219 brazing Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960004588 cilostazol Drugs 0.000 description 1
- RRGUKTPIGVIEKM-UHFFFAOYSA-N cilostazol Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCCC1=NN=NN1C1CCCCC1 RRGUKTPIGVIEKM-UHFFFAOYSA-N 0.000 description 1
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 1
- 229960003009 clopidogrel Drugs 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000007428 craniotomy Methods 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 108010078659 efegatran Proteins 0.000 description 1
- 229950009814 efegatran Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960004468 eptifibatide Drugs 0.000 description 1
- GLGOPUHVAZCPRB-LROMGURASA-N eptifibatide Chemical compound N1C(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]1CC1=CN=C2[C]1C=CC=C2 GLGOPUHVAZCPRB-LROMGURASA-N 0.000 description 1
- ZHCINJQZDFCSEL-CYBMUJFWSA-N ethyl (3s)-3-[[4-(4-carbamimidoylanilino)-4-oxobutanoyl]amino]pent-4-ynoate Chemical compound CCOC(=O)C[C@@H](C#C)NC(=O)CCC(=O)NC1=CC=C(C(N)=N)C=C1 ZHCINJQZDFCSEL-CYBMUJFWSA-N 0.000 description 1
- VJDOPFARMOLELX-ZDUSSCGKSA-N ethyl 3-[[(3s)-1-(4-carbamimidoylphenyl)-2-oxopyrrolidin-3-yl]carbamoylamino]propanoate Chemical compound O=C1[C@@H](NC(=O)NCCC(=O)OCC)CCN1C1=CC=C(C(N)=N)C=C1 VJDOPFARMOLELX-ZDUSSCGKSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 229950008851 fradafiban Drugs 0.000 description 1
- IKZACQMAVUIGPY-HOTGVXAUSA-N fradafiban Chemical compound C1=CC(C(=N)N)=CC=C1C(C=C1)=CC=C1OC[C@H]1NC(=O)[C@H](CC(O)=O)C1 IKZACQMAVUIGPY-HOTGVXAUSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000012977 invasive surgical procedure Methods 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 108010073077 klerval Proteins 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229950003178 lamifiban Drugs 0.000 description 1
- FPKOGTAFKSLZLD-FQEVSTJZSA-N lamifiban Chemical compound C1=CC(C(=N)N)=CC=C1C(=O)N[C@H](C(=O)N1CCC(CC1)OCC(O)=O)CC1=CC=C(O)C=C1 FPKOGTAFKSLZLD-FQEVSTJZSA-N 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- PGCFXITVMNNKON-ROUUACIJSA-N lefradafiban Chemical compound N1C(=O)[C@H](CC(=O)OC)C[C@H]1COC1=CC=C(C=2C=CC(=CC=2)C(=N)NC(=O)OC)C=C1 PGCFXITVMNNKON-ROUUACIJSA-N 0.000 description 1
- 229950011635 lefradafiban Drugs 0.000 description 1
- 229950010501 lotrafiban Drugs 0.000 description 1
- 239000003055 low molecular weight heparin Substances 0.000 description 1
- 229940127215 low-molecular weight heparin Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229950002383 orbofiban Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229940090007 persantine Drugs 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- ZONODCCBXBRQEZ-UHFFFAOYSA-N platinum tungsten Chemical compound [W].[Pt] ZONODCCBXBRQEZ-UHFFFAOYSA-N 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920006124 polyolefin elastomer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 150000003815 prostacyclins Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 108091006082 receptor inhibitors Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000003685 thermal hair damage Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 108010065972 tick anticoagulant peptide Proteins 0.000 description 1
- PHWBOXQYWZNQIN-UHFFFAOYSA-N ticlopidine Chemical compound ClC1=CC=CC=C1CN1CC(C=CS2)=C2CC1 PHWBOXQYWZNQIN-UHFFFAOYSA-N 0.000 description 1
- 229960005001 ticlopidine Drugs 0.000 description 1
- 229960003425 tirofiban Drugs 0.000 description 1
- COKMIXFXJJXBQG-NRFANRHFSA-N tirofiban Chemical compound C1=CC(C[C@H](NS(=O)(=O)CCCC)C(O)=O)=CC=C1OCCCCC1CCNCC1 COKMIXFXJJXBQG-NRFANRHFSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- SBHRWOBHKASWGU-UHFFFAOYSA-M tridodecyl(methyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CCCCCCCCCCCC SBHRWOBHKASWGU-UHFFFAOYSA-M 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229950007952 vapiprost Drugs 0.000 description 1
- 108010047303 von Willebrand Factor Proteins 0.000 description 1
- 102100036537 von Willebrand factor Human genes 0.000 description 1
- 229960001134 von willebrand factor Drugs 0.000 description 1
- 229960005080 warfarin Drugs 0.000 description 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 229950004893 xemilofiban Drugs 0.000 description 1
- ZXIBCJHYVWYIKI-PZJWPPBQSA-N ximelagatran Chemical compound C1([C@@H](NCC(=O)OCC)C(=O)N2[C@@H](CC2)C(=O)NCC=2C=CC(=CC=2)C(\N)=N\O)CCCCC1 ZXIBCJHYVWYIKI-PZJWPPBQSA-N 0.000 description 1
- 229960001522 ximelagatran Drugs 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
- A61B17/12118—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12177—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22067—Blocking; Occlusion
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Surgical Instruments (AREA)
- External Artificial Organs (AREA)
- Prostheses (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25854109P | 2009-11-05 | 2009-11-05 | |
| US61/258,541 | 2009-11-05 | ||
| US29476010P | 2010-01-13 | 2010-01-13 | |
| US61/294,760 | 2010-01-13 | ||
| US33413010P | 2010-05-12 | 2010-05-12 | |
| US61/334,130 | 2010-05-12 | ||
| PCT/US2010/055494 WO2011057002A2 (en) | 2009-11-05 | 2010-11-04 | Multiple layer filamentary devices or treatment of vascular defects |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2010315106A1 true AU2010315106A1 (en) | 2012-05-17 |
Family
ID=43970761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2010315106A Abandoned AU2010315106A1 (en) | 2009-11-05 | 2010-11-04 | Multiple layer filamentary devices or treatment of vascular defects |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20110152993A1 (enExample) |
| EP (1) | EP2496299B1 (enExample) |
| JP (1) | JP2013509914A (enExample) |
| CN (1) | CN102639181A (enExample) |
| AU (1) | AU2010315106A1 (enExample) |
| BR (1) | BR112012010758A2 (enExample) |
| CA (1) | CA2778639A1 (enExample) |
| WO (1) | WO2011057002A2 (enExample) |
Families Citing this family (214)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7686825B2 (en) | 2004-03-25 | 2010-03-30 | Hauser David L | Vascular filter device |
| EP2460476B1 (de) * | 2007-04-16 | 2020-11-25 | Occlutech Holding AG | Occluder zum Verschließen eines Herzohres und Herstellungsverfahren dafür |
| US20110022149A1 (en) | 2007-06-04 | 2011-01-27 | Cox Brian J | Methods and devices for treatment of vascular defects |
| US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
| JP5610542B2 (ja) | 2008-04-21 | 2014-10-22 | コヴィディエン リミテッド パートナーシップ | ブレードボール塞栓装置および送達システム |
| US12004750B2 (en) | 2008-05-01 | 2024-06-11 | Aneuclose Llc | Methods for creating an expandable two-part intrasacular aneurysm occlusion device from a tubular mesh |
| US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
| US11357511B2 (en) | 2008-05-01 | 2022-06-14 | Aneuclose Llc | Intrasacular aneurysm occlusion device with globular first configuration and bowl-shaped second configuration |
| US11471164B2 (en) | 2008-05-01 | 2022-10-18 | Aneuclose Llc | Methods of occluding a cerebral aneurysm by inserting embolic members or material into an intrasacular implant |
| US11484322B2 (en) | 2018-01-03 | 2022-11-01 | Aneuclose Llc | Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac |
| US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
| US11471163B2 (en) | 2008-05-01 | 2022-10-18 | Aneuclose Llc | Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies |
| US11583289B2 (en) | 2008-05-01 | 2023-02-21 | Aneuclose Llc | Aneurysm-occluding mesh ribbon with a series of loops or segments having distal-to-proximal variation in size, shape, and/or orientation |
| US11464518B2 (en) | 2008-05-01 | 2022-10-11 | Aneuclose Llc | Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms |
| WO2009135166A2 (en) * | 2008-05-02 | 2009-11-05 | Sequent Medical Inc. | Filamentary devices for treatment of vascular defects |
| US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
| BRPI0916353A2 (pt) | 2008-07-22 | 2018-06-12 | Micro Therapeutics Inc | dispositivos de remodelação |
| US9402707B2 (en) | 2008-07-22 | 2016-08-02 | Neuravi Limited | Clot capture systems and associated methods |
| JP2013509914A (ja) | 2009-11-05 | 2013-03-21 | シークエント メディカル， インコーポレイテッド | 複数層フィラメント状デバイスまたは血管障害処置 |
| WO2011057277A2 (en) | 2009-11-09 | 2011-05-12 | Nfocus Neuromedical, Inc. | Braid ball embolic device features |
| US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
| CN102740799A (zh) | 2010-01-28 | 2012-10-17 | 泰科保健集团有限合伙公司 | 脉管重塑装置 |
| WO2011094634A1 (en) | 2010-01-28 | 2011-08-04 | Micro Therapeutics, Inc. | Vascular remodeling device |
| WO2011106426A1 (en) | 2010-02-23 | 2011-09-01 | Maria Aboytes | Devices and methods for vascular recanalization |
| US10568628B2 (en) * | 2017-05-23 | 2020-02-25 | Muffin Incorporated | Closing device for tissue openings |
| US20180049731A1 (en) * | 2010-04-29 | 2018-02-22 | Muffin Incorporated | Closing device for tissue openings |
| CN103179909A (zh) * | 2010-09-06 | 2013-06-26 | 诺沃泰科医药股份有限公司 | 用于闭合血管中的开口或空腔的装置 |
| EP2613735B1 (en) | 2010-09-10 | 2018-05-09 | Covidien LP | Devices for the treatment of vascular defects |
| US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
| CN101933850B (zh) * | 2010-09-16 | 2012-07-18 | 先健科技(深圳)有限公司 | 封堵器及其制造方法 |
| EP2629684B1 (en) | 2010-10-22 | 2018-07-25 | Neuravi Limited | Clot engagement and removal system |
| CN103442653B (zh) * | 2011-02-11 | 2016-06-01 | 柯惠有限合伙公司 | 两阶段展开动脉瘤栓塞装置 |
| US11259824B2 (en) | 2011-03-09 | 2022-03-01 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
| EP4566553A3 (en) | 2011-03-09 | 2025-08-06 | Neuravi Limited | A clot retrieval device for removing occlusive clot from a blood vessel |
| US12076037B2 (en) | 2011-03-09 | 2024-09-03 | Neuravi Limited | Systems and methods to restore perfusion to a vessel |
| US9089332B2 (en) | 2011-03-25 | 2015-07-28 | Covidien Lp | Vascular remodeling device |
| WO2013005195A1 (en) * | 2011-07-07 | 2013-01-10 | Jayandiran Pillai | Aneurysm occluder |
| US20140343602A1 (en) * | 2011-08-19 | 2014-11-20 | Brian J. Cox | Expandable occlusion device and methods |
| US9060886B2 (en) | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
| WO2013060856A2 (en) * | 2011-10-27 | 2013-05-02 | Occlutech Holding Ag | A medical implant for occluding an opening in a body and a method of producing such a medical implant |
| EP2606829A1 (en) * | 2011-12-23 | 2013-06-26 | Occlutech Holding AG | A medical implant, a kit and a method of manufacturing a 3D fabric of strands for forming a medical implant |
| US8758389B2 (en) * | 2011-11-18 | 2014-06-24 | Aga Medical Corporation | Devices and methods for occluding abnormal openings in a patient's vasculature |
| EP2800528A4 (en) * | 2012-01-06 | 2015-12-02 | Inceptus Medical LLC | DEABLABLE OCCLUSION DEVICES AND USE METHOD THEREFOR |
| US9113890B2 (en) | 2012-02-06 | 2015-08-25 | Aga Medical Corporation | Devices and methods for occluding vascular abnormalities |
| US10258448B2 (en) * | 2012-03-22 | 2019-04-16 | C.R. Bard, Inc. | Implantable prosthesis for soft tissue repair |
| DE102012102844B4 (de) * | 2012-04-02 | 2020-03-19 | Acandis Gmbh | Okklusionsvorrichtung zur Implantation innerhalb eines Aneurysmas und Anordnung mit einer derartigen Okklusionsvorrichtung |
| US20150133989A1 (en) * | 2012-04-20 | 2015-05-14 | Inceptus Medical, Llc | Expandable occlusion devices and methods of use |
| WO2014011865A1 (en) * | 2012-07-13 | 2014-01-16 | Boston Scientific Scimed, Inc. | Occlusion device for an atrial appendage |
| EP2897536B1 (en) | 2012-09-24 | 2020-08-19 | Inari Medical, Inc. | Device for treating vascular occlusion |
| US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
| US20140135811A1 (en) | 2012-11-13 | 2014-05-15 | Covidien Lp | Occlusive devices |
| US8597323B1 (en) | 2012-11-16 | 2013-12-03 | Sequent Medical, Inc. | Delivery and detachment systems and methods for vascular implants |
| US8784434B2 (en) | 2012-11-20 | 2014-07-22 | Inceptus Medical, Inc. | Methods and apparatus for treating embolism |
| CN103006286B (zh) * | 2012-12-18 | 2015-07-08 | 邹旭华 | 一种可显影封闭式编织体植入物及输送装置 |
| US10342546B2 (en) | 2013-01-14 | 2019-07-09 | Microvention, Inc. | Occlusive device |
| US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
| WO2014134568A2 (en) | 2013-03-01 | 2014-09-04 | The Regents Of The University Of California | Apparatus and methods for bidirectional hyperelastic stent covers |
| ES2708786T3 (es) | 2013-03-14 | 2019-04-11 | Neuravi Ltd | Dispositivo de recuperación de coágulos para eliminar coágulos oclusivos de un vaso sanguíneo |
| ES2985753T3 (es) | 2013-03-14 | 2024-11-07 | Neuravi Ltd | Dispositivos y métodos para la eliminación de obstrucciones agudas de los vasos sanguíneos |
| US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
| US9433429B2 (en) | 2013-03-14 | 2016-09-06 | Neuravi Limited | Clot retrieval devices |
| US8715315B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment systems |
| US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
| WO2014144980A1 (en) | 2013-03-15 | 2014-09-18 | Covidien Lp | Occlusive device |
| WO2014145005A2 (en) * | 2013-03-15 | 2014-09-18 | Covidien Lp | Occlusive device |
| US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
| CN109730806B (zh) | 2013-03-15 | 2023-01-24 | 伊瑟拉医疗公司 | 脉管治疗装置和方法 |
| US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
| US9259237B2 (en) | 2013-07-12 | 2016-02-16 | Inceptus Medical, Llc | Methods and apparatus for treating pulmonary embolism |
| US8870948B1 (en) | 2013-07-17 | 2014-10-28 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
| US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
| US9078658B2 (en) | 2013-08-16 | 2015-07-14 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
| US10238406B2 (en) | 2013-10-21 | 2019-03-26 | Inari Medical, Inc. | Methods and apparatus for treating embolism |
| WO2015120155A1 (en) * | 2014-02-06 | 2015-08-13 | Boston Scientific Scimed, Inc. | Occlusion device detachable by inflation of a balloon |
| US11154302B2 (en) | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
| US11076860B2 (en) | 2014-03-31 | 2021-08-03 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
| US9629635B2 (en) | 2014-04-14 | 2017-04-25 | Sequent Medical, Inc. | Devices for therapeutic vascular procedures |
| MX381828B (es) | 2014-04-30 | 2025-03-13 | Cerus Endovascular Ltd | Dispositivo de oclusión. |
| EP3145423B1 (en) | 2014-05-20 | 2020-12-30 | Muffin Incorporated | Aneurysm stop pressure system |
| WO2015191646A1 (en) | 2014-06-09 | 2015-12-17 | Inceptus Medical, Llc | Retraction and aspiration device for treating embolism and associated systems and methods |
| WO2016020922A2 (en) * | 2014-08-07 | 2016-02-11 | Perflow Medical Ltd. | Aneurysm treatment device and method |
| EP3171793B1 (en) * | 2014-08-14 | 2024-07-24 | Microvention, Inc. | Filamentary devices for treatment of vascular defects |
| JP6348052B2 (ja) * | 2014-11-19 | 2018-06-27 | グンゼ株式会社 | 医療用材料 |
| CN111743601A (zh) | 2014-11-26 | 2020-10-09 | 尼尔拉维有限公司 | 从血管除去阻塞性血栓的取血栓装置 |
| US10617435B2 (en) | 2014-11-26 | 2020-04-14 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
| US11253278B2 (en) | 2014-11-26 | 2022-02-22 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
| US10869755B2 (en) | 2014-12-09 | 2020-12-22 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
| EP3247441B1 (en) | 2015-01-23 | 2023-11-08 | Contego Medical, Inc. | Interventional device having an integrated embolic filter |
| CA2976260C (en) | 2015-02-25 | 2024-02-06 | Galaxy Therapeutics, Llc | System for and method of treating aneurysms |
| US9375333B1 (en) | 2015-03-06 | 2016-06-28 | Covidien Lp | Implantable device detachment systems and associated devices and methods |
| AU2016262564B2 (en) | 2015-05-14 | 2020-11-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| WO2018136959A1 (en) | 2017-01-23 | 2018-07-26 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| EP3294220B1 (en) | 2015-05-14 | 2023-12-06 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
| EP3340894A4 (en) * | 2015-08-24 | 2019-06-12 | Neurvana Medical LLC | DEVICES, METHODS, PROCESSES, AND INTRASACULAR OCCLUSION SYSTEMS |
| US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
| US10342571B2 (en) | 2015-10-23 | 2019-07-09 | Inari Medical, Inc. | Intravascular treatment of vascular occlusion and associated devices, systems, and methods |
| AU2016341439B2 (en) | 2015-10-23 | 2021-07-08 | Inari Medical, Inc. | Intravascular treatment of vascular occlusion and associated devices, systems, and methods |
| US9700332B2 (en) | 2015-10-23 | 2017-07-11 | Inari Medical, Inc. | Intravascular treatment of vascular occlusion and associated devices, systems, and methods |
| EP3367925B1 (en) * | 2015-10-28 | 2021-08-25 | Jayandiran Pillai | Aneurysm occluder |
| WO2017072695A1 (en) | 2015-10-28 | 2017-05-04 | Jayandiran Pillai | Aneurysm occluder |
| CA3005686A1 (en) | 2015-12-07 | 2017-06-15 | Cerus Endovascular Limited | Occlusion device |
| WO2017106877A1 (en) | 2015-12-18 | 2017-06-22 | Inari Medical, Inc. | Catheter shaft and associated devices, systems, and methods |
| CA3014316C (en) * | 2016-02-10 | 2025-08-12 | Microvention, Inc. | Devices for vascular occlusion |
| EP3416568A4 (en) | 2016-02-16 | 2019-10-16 | Insera Therapeutics, Inc. | SUCTION DEVICES AND ANCHORED FLOW REVERSING DEVICES |
| WO2017153603A1 (en) | 2016-03-11 | 2017-09-14 | Cerus Endovascular Limited | Occlusion device |
| EP3429479A4 (en) * | 2016-03-17 | 2019-10-23 | Swaminathan Jayaraman | CLOSURE OF ANATOMICAL STRUCTURES |
| US12232737B2 (en) | 2016-03-17 | 2025-02-25 | Eclipse Medical Limited | Occluding anatomical structures |
| EP3468479B1 (en) * | 2016-06-10 | 2021-08-04 | Terumo Corporation | Vessel occluder |
| WO2017218877A1 (en) * | 2016-06-17 | 2017-12-21 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
| US10478195B2 (en) | 2016-08-04 | 2019-11-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| KR102494176B1 (ko) | 2016-09-06 | 2023-02-02 | 뉴라비 리미티드 | 혈관으로부터 폐색 혈전을 제거하기 위한 혈전 회수 장치 |
| US10314684B2 (en) | 2016-09-07 | 2019-06-11 | Daniel Ezra Walzman | Simultaneous rotating separator, irrigator microcatheter for thrombectomy |
| US11439492B2 (en) | 2016-09-07 | 2022-09-13 | Daniel Ezra Walzman | Lasso filter tipped microcatheter for simultaneous rotating separator, irrigator for thrombectomy and method for use |
| US12138149B2 (en) | 2016-09-07 | 2024-11-12 | Daniel Ezra Walzman | Endovascular devices and methods with filtering elements |
| US11877752B2 (en) | 2016-09-07 | 2024-01-23 | Daniel Ezra Walzman | Filterless aspiration, irrigating, macerating, rotating microcatheter and method of use |
| US12369932B2 (en) | 2016-09-07 | 2025-07-29 | Daniel Ezra Walzman | Methods and devices to ameliorate vascular obstruction |
| US11259820B2 (en) | 2016-09-07 | 2022-03-01 | Daniel Ezra Walzman | Methods and devices to ameliorate vascular obstruction |
| CN113215721B (zh) | 2016-10-14 | 2023-02-17 | 因赛普特斯医学有限责任公司 | 编织机器和使用方法 |
| US20180206851A1 (en) * | 2016-10-19 | 2018-07-26 | Daniel E. Walzman | Hydrogel intrasaccular occlusion device |
| US10576099B2 (en) | 2016-10-21 | 2020-03-03 | Covidien Lp | Injectable scaffold for treatment of intracranial aneurysms and related technology |
| FI3528717T3 (fi) | 2016-10-24 | 2024-08-09 | Inari Medical Inc | Laitteita verisuonitukoksen hoitamiseen |
| US10543015B2 (en) | 2016-12-05 | 2020-01-28 | Daniel Ezra Walzman | Mesh disc for saccular aneurysms and cover for saccular out-pouching |
| US10603070B2 (en) | 2016-12-05 | 2020-03-31 | Daniel E. Walzman | Alternative use for hydrogel intrasaccular occlusion device with a spring for structural support |
| US10448970B2 (en) * | 2016-12-05 | 2019-10-22 | Daniel E. Walzman | Alternative use for hydrogel intrasaccular occlusion device with telescoping central support element |
| US10548607B2 (en) | 2016-12-05 | 2020-02-04 | Daniel Ezra Walzman | Mesh caps |
| US12426885B2 (en) | 2016-12-05 | 2025-09-30 | Daniel Ezra Walzman | Mesh cap for ameliorating outpouchings |
| EP4209196A1 (en) | 2017-01-23 | 2023-07-12 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| CA3054556A1 (en) * | 2017-02-23 | 2018-08-30 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
| JP7296317B2 (ja) | 2017-02-24 | 2023-06-22 | インセプタス メディカル リミテッド ライアビリティ カンパニー | 血管閉塞装置および方法 |
| US10881413B2 (en) * | 2017-03-24 | 2021-01-05 | Sequent Medical, Inc. | Systems and methods for embolization of body structures |
| JP7356965B2 (ja) * | 2017-08-17 | 2023-10-05 | アリッサ メディカル， インコーポレイテッド | 流れ減衰装置 |
| CA3073232C (en) | 2017-08-21 | 2023-08-29 | Cerus Endovascular Limited | Occlusion device |
| US10675036B2 (en) | 2017-08-22 | 2020-06-09 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| CN111295221B (zh) | 2017-09-06 | 2023-04-11 | 伊纳里医疗有限公司 | 止血阀及其使用方法 |
| CN111542657B (zh) | 2017-10-14 | 2022-08-16 | 因赛普特斯医学有限责任公司 | 编织机及其使用方法 |
| WO2019118374A1 (en) * | 2017-12-12 | 2019-06-20 | Penumbra, Inc. | Vascular cages and methods of making and using the same |
| US10716574B2 (en) | 2017-12-22 | 2020-07-21 | DePuy Synthes Products, Inc. | Aneurysm device and delivery method |
| US10751065B2 (en) | 2017-12-22 | 2020-08-25 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
| US11185335B2 (en) | 2018-01-19 | 2021-11-30 | Galaxy Therapeutics Inc. | System for and method of treating aneurysms |
| US10905430B2 (en) | 2018-01-24 | 2021-02-02 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
| US11154314B2 (en) | 2018-01-26 | 2021-10-26 | Inari Medical, Inc. | Single insertion delivery system for treating embolism and associated systems and methods |
| US11058430B2 (en) | 2018-05-25 | 2021-07-13 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
| US11596412B2 (en) | 2018-05-25 | 2023-03-07 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
| US10939915B2 (en) | 2018-05-31 | 2021-03-09 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
| US11051825B2 (en) | 2018-08-08 | 2021-07-06 | DePuy Synthes Products, Inc. | Delivery system for embolic braid |
| DK3836855T3 (en) | 2018-08-13 | 2024-11-18 | Inari Medical Inc | System for treating embolism and associated devices and methods |
| US10842498B2 (en) | 2018-09-13 | 2020-11-24 | Neuravi Limited | Systems and methods of restoring perfusion to a vessel |
| US11123077B2 (en) | 2018-09-25 | 2021-09-21 | DePuy Synthes Products, Inc. | Intrasaccular device positioning and deployment system |
| US11406416B2 (en) | 2018-10-02 | 2022-08-09 | Neuravi Limited | Joint assembly for vasculature obstruction capture device |
| US11076861B2 (en) | 2018-10-12 | 2021-08-03 | DePuy Synthes Products, Inc. | Folded aneurysm treatment device and delivery method |
| JP7475020B2 (ja) | 2018-10-25 | 2024-04-26 | 株式会社東海メディカルプロダクツ | 医療用デバイス |
| US11406392B2 (en) | 2018-12-12 | 2022-08-09 | DePuy Synthes Products, Inc. | Aneurysm occluding device for use with coagulating agents |
| CN111388043A (zh) | 2018-12-17 | 2020-07-10 | 柯惠有限合伙公司 | 闭塞装置 |
| US11272939B2 (en) | 2018-12-18 | 2022-03-15 | DePuy Synthes Products, Inc. | Intrasaccular flow diverter for treating cerebral aneurysms |
| WO2020139544A2 (en) * | 2018-12-27 | 2020-07-02 | Stryker Corporation | Shape adaptable multi-layered intra-saccular flow reduction device and methods of manufacturing same |
| US11134953B2 (en) | 2019-02-06 | 2021-10-05 | DePuy Synthes Products, Inc. | Adhesive cover occluding device for aneurysm treatment |
| JP7469323B2 (ja) * | 2019-03-15 | 2024-04-16 | マイクロベンション インコーポレイテッド | 血管障害の治療のためのフィラメント状デバイス |
| WO2020190630A1 (en) * | 2019-03-15 | 2020-09-24 | Sequent Medical, Inc. | Filamentary devices having a flexible joint for treatment of vascular defects |
| WO2020190639A1 (en) | 2019-03-15 | 2020-09-24 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
| US11337706B2 (en) | 2019-03-27 | 2022-05-24 | DePuy Synthes Products, Inc. | Aneurysm treatment device |
| US11413046B2 (en) | 2019-05-21 | 2022-08-16 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
| US10653425B1 (en) | 2019-05-21 | 2020-05-19 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
| US11602350B2 (en) | 2019-12-05 | 2023-03-14 | DePuy Synthes Products, Inc. | Intrasaccular inverting braid with highly flexible fill material |
| US11672542B2 (en) | 2019-05-21 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable ball segment |
| US11278292B2 (en) | 2019-05-21 | 2022-03-22 | DePuy Synthes Products, Inc. | Inverting braided aneurysm treatment system and method |
| US11497504B2 (en) | 2019-05-21 | 2022-11-15 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable implanted braid |
| US12446886B2 (en) | 2019-05-21 | 2025-10-21 | DePuy Synthes Products, Inc. | Semispherical braided aneurysm treatment system and method |
| US11607226B2 (en) | 2019-05-21 | 2023-03-21 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device with corrugations |
| US12102327B2 (en) | 2019-05-25 | 2024-10-01 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
| US11058431B2 (en) | 2019-05-25 | 2021-07-13 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
| US20210007754A1 (en) * | 2019-07-12 | 2021-01-14 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
| EP3771437A1 (fr) * | 2019-07-29 | 2021-02-03 | Université de Montpellier | Dispositif intra-anévrismal |
| CN120284394A (zh) | 2019-10-16 | 2025-07-11 | 伊纳里医疗有限公司 | 用于治疗血管闭塞的系统，装置，和方法 |
| US11712231B2 (en) | 2019-10-29 | 2023-08-01 | Neuravi Limited | Proximal locking assembly design for dual stent mechanical thrombectomy device |
| WO2021092618A1 (en) | 2019-11-04 | 2021-05-14 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
| US11517340B2 (en) | 2019-12-03 | 2022-12-06 | Neuravi Limited | Stentriever devices for removing an occlusive clot from a vessel and methods thereof |
| US11457926B2 (en) | 2019-12-18 | 2022-10-04 | DePuy Synthes Products, Inc. | Implant having an intrasaccular section and intravascular section |
| US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
| US20210282789A1 (en) | 2020-03-11 | 2021-09-16 | Microvention, Inc. | Multiple layer devices for treatment of vascular defects |
| US12023034B2 (en) | 2020-03-11 | 2024-07-02 | Microvention, Inc. | Devices for treatment of vascular defects |
| US12070220B2 (en) | 2020-03-11 | 2024-08-27 | Microvention, Inc. | Devices having multiple permeable shells for treatment of vascular defects |
| US11871946B2 (en) | 2020-04-17 | 2024-01-16 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
| US11717308B2 (en) | 2020-04-17 | 2023-08-08 | Neuravi Limited | Clot retrieval device for removing heterogeneous clots from a blood vessel |
| US11730501B2 (en) | 2020-04-17 | 2023-08-22 | Neuravi Limited | Floating clot retrieval device for removing clots from a blood vessel |
| US20210338247A1 (en) * | 2020-05-04 | 2021-11-04 | DePuy Synthes Products, Inc. | Double layer braid |
| US11931041B2 (en) | 2020-05-12 | 2024-03-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| US11737771B2 (en) | 2020-06-18 | 2023-08-29 | Neuravi Limited | Dual channel thrombectomy device |
| US11937836B2 (en) | 2020-06-22 | 2024-03-26 | Neuravi Limited | Clot retrieval system with expandable clot engaging framework |
| US11395669B2 (en) | 2020-06-23 | 2022-07-26 | Neuravi Limited | Clot retrieval device with flexible collapsible frame |
| US11439418B2 (en) | 2020-06-23 | 2022-09-13 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
| EP4171852A1 (en) * | 2020-06-25 | 2023-05-03 | BAE SYSTEMS plc | Structural simulation of additively manufactured components |
| US12161344B2 (en) * | 2020-07-31 | 2024-12-10 | Covidien Lp | Expandable devices for treating body lumens |
| CN114098880B (zh) * | 2020-08-31 | 2025-08-01 | 微创神通医疗科技（上海）有限公司 | 血管瘤封堵装置、血管瘤封堵治疗装置及血管瘤封堵系统 |
| US12127743B2 (en) * | 2020-09-23 | 2024-10-29 | DePuy Synthes Products, Inc. | Inverting braided aneurysm implant with dome feature |
| US11864781B2 (en) | 2020-09-23 | 2024-01-09 | Neuravi Limited | Rotating frame thrombectomy device |
| US20220192678A1 (en) * | 2020-12-18 | 2022-06-23 | Microvention, Inc. | Filamentary devices for treatment of vascular defects |
| US11937837B2 (en) | 2020-12-29 | 2024-03-26 | Neuravi Limited | Fibrin rich / soft clot mechanical thrombectomy device |
| CN112690855B (zh) * | 2020-12-31 | 2023-02-03 | 先健科技(深圳)有限公司 | 封堵器及封堵装置 |
| WO2022149141A1 (en) * | 2021-01-10 | 2022-07-14 | Luseed Vascular Ltd. | Intravascular device |
| US12029442B2 (en) | 2021-01-14 | 2024-07-09 | Neuravi Limited | Systems and methods for a dual elongated member clot retrieval apparatus |
| EP4284263A4 (en) | 2021-01-27 | 2024-06-26 | Galaxy Therapeutics, Inc. | SYSTEMS AND METHODS FOR TREATING ANEURYSMS |
| JP7315969B2 (ja) * | 2021-01-27 | 2023-07-27 | 株式会社SG-1Medical | 血管プラグ及び治療デバイス |
| US12064130B2 (en) | 2021-03-18 | 2024-08-20 | Neuravi Limited | Vascular obstruction retrieval device having sliding cages pinch mechanism |
| CN113180781B (zh) * | 2021-06-01 | 2025-03-21 | 上海融脉医疗科技有限公司 | 一种卷绕式网盘支架及其输送装置 |
| US11974764B2 (en) | 2021-06-04 | 2024-05-07 | Neuravi Limited | Self-orienting rotating stentriever pinching cells |
| CN113491556B (zh) * | 2021-06-25 | 2022-07-26 | 四川艾迈思生物医疗科技股份有限公司 | 一种栓塞微导管组件 |
| US12446891B2 (en) * | 2021-08-30 | 2025-10-21 | Microvention, Inc. | Devices for treatment of vascular defects |
| AU2023208030A1 (en) | 2022-01-11 | 2024-07-18 | Inari Medical, Inc. | Devices for removing clot material from intravascularly implanted devices, and associated systems and methods |
| CN114246631A (zh) * | 2022-02-28 | 2022-03-29 | 上海介入医疗器械有限公司 | 封堵器及封堵组件 |
| US12408923B2 (en) | 2022-03-02 | 2025-09-09 | Covidien Lp | Occlusive devices with thrombogenic inserts |
| KR102772752B1 (ko) * | 2022-04-12 | 2025-02-26 | 한스바이오메드 주식회사 | 다층 구조 및 복합 소재를 포함하는 혈류 제한 장치 |
| US20230404590A1 (en) * | 2022-06-15 | 2023-12-21 | DePuy Synthes Products, Inc. | Inverting braided aneurysm treatment system having a semi-frustoconically-shaped portion |
| AU2024207180A1 (en) | 2023-01-09 | 2025-07-17 | Inari Medical, Inc. | Catheter for use with clot treatment systems |
| US12465382B1 (en) | 2024-05-10 | 2025-11-11 | Inari Medical, Inc. | Mechanical thrombectomy assemblies with relief features, and associated devices, systems, and methods |
Family Cites Families (230)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3874388A (en) | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
| JPS52141092A (en) | 1976-05-20 | 1977-11-25 | Nippon Zeon Co | Blood bessel catheter |
| US4282875A (en) | 1979-01-24 | 1981-08-11 | Serbinenko Fedor A | Occlusive device |
| US4346712A (en) | 1979-04-06 | 1982-08-31 | Kuraray Company, Ltd. | Releasable balloon catheter |
| US4675361A (en) | 1980-02-29 | 1987-06-23 | Thoratec Laboratories Corp. | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
| DK151404C (da) | 1984-05-23 | 1988-07-18 | Cook Europ Aps William | Sammenklappeligt filter til implantation i en patients blodkar |
| SE453258B (sv) | 1986-04-21 | 1988-01-25 | Medinvent Sa | Elastisk, sjelvexpanderande protes samt forfarande for dess framstellning |
| US4729278A (en) * | 1987-05-04 | 1988-03-08 | Rockwell International Corporation | Vertical rotary braider |
| US5154705A (en) | 1987-09-30 | 1992-10-13 | Lake Region Manufacturing Co., Inc. | Hollow lumen cable apparatus |
| US5165421A (en) | 1987-09-30 | 1992-11-24 | Lake Region Manufacturing Co., Inc. | Hollow lumen cable apparatus |
| FR2624747A1 (fr) * | 1987-12-18 | 1989-06-23 | Delsanti Gerard | Dispositifs endo-arteriels amovibles destines a reparer des decollements de parois des arteres |
| US5263963A (en) | 1989-09-08 | 1993-11-23 | Advanced Cardiovascular Systems, Inc. | Expandable cage catheter for repairing a damaged blood vessel |
| US5122136A (en) | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| US5569245A (en) | 1990-03-13 | 1996-10-29 | The Regents Of The University Of California | Detachable endovascular occlusion device activated by alternating electric current |
| US5221261A (en) * | 1990-04-12 | 1993-06-22 | Schneider (Usa) Inc. | Radially expandable fixation member |
| US5071407A (en) | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
| US5108407A (en) * | 1990-06-08 | 1992-04-28 | Rush-Presbyterian St. Luke's Medical Center | Method and apparatus for placement of an embolic coil |
| JPH0447415A (ja) | 1990-06-14 | 1992-02-17 | Amada Co Ltd | ワーク搬送ロボットにおけるリニアモータの制御方法及びその装置 |
| US5158545A (en) | 1991-05-02 | 1992-10-27 | Brigham And Women's Hospital | Diameter expansion cannula |
| JP2961287B2 (ja) * | 1991-10-18 | 1999-10-12 | グンゼ株式会社 | 生体管路拡張具、その製造方法およびステント |
| ATE247435T1 (de) * | 1992-05-08 | 2003-09-15 | Schneider Usa Inc | Stent für den oesophagus |
| US5382259A (en) * | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
| US5334210A (en) | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
| US5536247A (en) | 1993-06-10 | 1996-07-16 | Scimed Life Systems, Inc. | Method of treating cardiac conduction defects |
| RU2089131C1 (ru) | 1993-12-28 | 1997-09-10 | Сергей Апполонович Пульнев | Стент |
| JP2880070B2 (ja) | 1994-03-31 | 1999-04-05 | 株式会社カネカメディックス | 生体内留置部材を有する医療用ワイヤー |
| CA2194671A1 (en) | 1994-07-08 | 1996-01-25 | Ev3 Inc. | Method of forming medical devices; intravascular occlusion devices |
| US5846261A (en) | 1994-07-08 | 1998-12-08 | Aga Medical Corp. | Percutaneous catheter directed occlusion devices |
| US5725552A (en) * | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
| US6123715A (en) | 1994-07-08 | 2000-09-26 | Amplatz; Curtis | Method of forming medical devices; intravascular occlusion devices |
| US5556687A (en) | 1994-10-14 | 1996-09-17 | Acromed Corporation | Composite structure suitable for use as a bone plate and method for making said structure |
| US5601595A (en) * | 1994-10-25 | 1997-02-11 | Scimed Life Systems, Inc. | Remobable thrombus filter |
| US5578074A (en) | 1994-12-22 | 1996-11-26 | Target Therapeutics, Inc. | Implant delivery method and assembly |
| NO962336L (no) * | 1995-06-06 | 1996-12-09 | Target Therapeutics Inc | Vaso-okklusiv spiral |
| US5989242A (en) | 1995-06-26 | 1999-11-23 | Trimedyne, Inc. | Therapeutic appliance releasing device |
| US5749883A (en) * | 1995-08-30 | 1998-05-12 | Halpern; David Marcos | Medical instrument |
| US6168622B1 (en) * | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
| WO1997027959A1 (en) | 1996-01-30 | 1997-08-07 | Medtronic, Inc. | Articles for and methods of making stents |
| US5733294A (en) * | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
| US5718159A (en) * | 1996-04-30 | 1998-02-17 | Schneider (Usa) Inc. | Process for manufacturing three-dimensional braided covered stent |
| US6592617B2 (en) * | 1996-04-30 | 2003-07-15 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
| US5927345A (en) | 1996-04-30 | 1999-07-27 | Target Therapeutics, Inc. | Super-elastic alloy braid structure |
| US6949116B2 (en) | 1996-05-08 | 2005-09-27 | Carag Ag | Device for plugging an opening such as in a wall of a hollow or tubular organ including biodegradable elements |
| US6190402B1 (en) * | 1996-06-21 | 2001-02-20 | Musc Foundation For Research Development | Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same |
| US5964797A (en) | 1996-08-30 | 1999-10-12 | Target Therapeutics, Inc. | Electrolytically deployable braided vaso-occlusion device |
| US5980554A (en) | 1997-05-05 | 1999-11-09 | Micro Therapeutics, Inc. | Wire frame partial flow obstruction for aneurysm treatment |
| US5951599A (en) * | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
| US5928260A (en) | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
| US7569066B2 (en) | 1997-07-10 | 2009-08-04 | Boston Scientific Scimed, Inc. | Methods and devices for the treatment of aneurysms |
| US5944733A (en) | 1997-07-14 | 1999-08-31 | Target Therapeutics, Inc. | Controlled detachable vasoocclusive member using mechanical junction and friction-enhancing member |
| GB9715241D0 (en) | 1997-07-18 | 1997-09-24 | Jeffree Martin A | Device for treating aneurysms |
| EP1006890B1 (en) | 1997-08-04 | 2006-09-20 | Boston Scientific Limited | Occlusion system for aneurysm repair |
| JP4127960B2 (ja) | 1997-08-05 | 2008-07-30 | ボストン サイエンティフィック リミテッド | 着脱可能な動脈瘤頸部ブリッジ |
| US6063070A (en) * | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
| US5916235A (en) | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
| US6086577A (en) | 1997-08-13 | 2000-07-11 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (III) |
| US5984929A (en) | 1997-08-29 | 1999-11-16 | Target Therapeutics, Inc. | Fast detaching electronically isolated implant |
| US6156061A (en) | 1997-08-29 | 2000-12-05 | Target Therapeutics, Inc. | Fast-detaching electrically insulated implant |
| US6066149A (en) | 1997-09-30 | 2000-05-23 | Target Therapeutics, Inc. | Mechanical clot treatment device with distal filter |
| US6511468B1 (en) * | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
| DE69838375T2 (de) | 1997-10-30 | 2008-01-17 | Kaneka Medix Corp. | Medizinische vorrichtung zum einbringen eines implantierbaren gegenstands |
| US6461370B1 (en) * | 1998-11-03 | 2002-10-08 | C. R. Bard, Inc. | Temporary vascular filter guide wire |
| US20040260333A1 (en) * | 1997-11-12 | 2004-12-23 | Dubrul William R. | Medical device and method |
| US5873907A (en) * | 1998-01-27 | 1999-02-23 | Endotex Interventional Systems, Inc. | Electrolytic stent delivery system and methods of use |
| US5944738A (en) | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
| WO1999039649A1 (en) | 1998-02-10 | 1999-08-12 | Dubrul William R | Occlusion, anchoring, tensioning and flow direction apparatus and methods for use |
| US5925060A (en) | 1998-03-13 | 1999-07-20 | B. Braun Celsa | Covered self-expanding vascular occlusion device |
| US6168615B1 (en) * | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
| US6463317B1 (en) | 1998-05-19 | 2002-10-08 | Regents Of The University Of Minnesota | Device and method for the endovascular treatment of aneurysms |
| JP4741728B2 (ja) | 1998-06-04 | 2011-08-10 | ニューヨーク・ユニバーシティ | 血管内薄膜デバイスおよびストロークの予防治療法 |
| US6139564A (en) | 1998-06-16 | 2000-10-31 | Target Therapeutics Inc. | Minimally occlusive flow disruptor stent for bridging aneurysm necks |
| US5935148A (en) * | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
| US6096175A (en) * | 1998-07-17 | 2000-08-01 | Micro Therapeutics, Inc. | Thin film stent |
| US7004962B2 (en) * | 1998-07-27 | 2006-02-28 | Schneider (Usa), Inc. | Neuroaneurysm occlusion and delivery device and method of using same |
| US6093199A (en) | 1998-08-05 | 2000-07-25 | Endovascular Technologies, Inc. | Intra-luminal device for treatment of body cavities and lumens and method of use |
| US6315709B1 (en) | 1998-08-07 | 2001-11-13 | Stereotaxis, Inc. | Magnetic vascular defect treatment system |
| US6478773B1 (en) | 1998-12-21 | 2002-11-12 | Micrus Corporation | Apparatus for deployment of micro-coil using a catheter |
| US6500149B2 (en) | 1998-08-31 | 2002-12-31 | Deepak Gandhi | Apparatus for deployment of micro-coil using a catheter |
| US7410482B2 (en) | 1998-09-04 | 2008-08-12 | Boston Scientific-Scimed, Inc. | Detachable aneurysm neck bridge |
| AU5905599A (en) | 1998-09-04 | 2000-03-27 | Boston Scientific Limited | Detachable aneurysm neck closure patch |
| US6277126B1 (en) * | 1998-10-05 | 2001-08-21 | Cordis Neurovascular Inc. | Heated vascular occlusion coil development system |
| US6152144A (en) | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
| US7044134B2 (en) | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
| US6368338B1 (en) * | 1999-03-05 | 2002-04-09 | Board Of Regents, The University Of Texas | Occlusion method and apparatus |
| US6428558B1 (en) | 1999-03-10 | 2002-08-06 | Cordis Corporation | Aneurysm embolization device |
| US6613074B1 (en) | 1999-03-10 | 2003-09-02 | Cordis Corporation | Endovascular aneurysm embolization device |
| US6203779B1 (en) * | 1999-03-19 | 2001-03-20 | Charlie Ricci | Methods for treating endoleaks during endovascular repair of abdominal aortic aneurysms |
| US20020169473A1 (en) * | 1999-06-02 | 2002-11-14 | Concentric Medical, Inc. | Devices and methods for treating vascular malformations |
| US6375668B1 (en) * | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
| US7052711B2 (en) * | 1999-09-02 | 2006-05-30 | Rice University | Nitric oxide-producing hydrogel materials |
| US6325815B1 (en) | 1999-09-21 | 2001-12-04 | Microvena Corporation | Temporary vascular filter |
| US6375670B1 (en) * | 1999-10-07 | 2002-04-23 | Prodesco, Inc. | Intraluminal filter |
| US6551303B1 (en) * | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
| US6689150B1 (en) | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
| US6994092B2 (en) * | 1999-11-08 | 2006-02-07 | Ev3 Sunnyvale, Inc. | Device for containing embolic material in the LAA having a plurality of tissue retention structures |
| US6790218B2 (en) | 1999-12-23 | 2004-09-14 | Swaminathan Jayaraman | Occlusive coil manufacture and delivery |
| US6350270B1 (en) * | 2000-01-24 | 2002-02-26 | Scimed Life Systems, Inc. | Aneurysm liner |
| US7740637B2 (en) | 2000-02-09 | 2010-06-22 | Micrus Endovascular Corporation | Apparatus and method for deployment of a therapeutic device using a catheter |
| US20020043456A1 (en) * | 2000-02-29 | 2002-04-18 | Ho Ken K. | Bimorphic, compositionally-graded, sputter-deposited, thin film shape memory device |
| US6346117B1 (en) * | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
| US6391037B1 (en) * | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
| US6632241B1 (en) | 2000-03-22 | 2003-10-14 | Endovascular Technologies, Inc. | Self-expanding, pseudo-braided intravascular device |
| US6719778B1 (en) * | 2000-03-24 | 2004-04-13 | Endovascular Technologies, Inc. | Methods for treatment of aneurysms |
| WO2001073133A1 (en) * | 2000-03-27 | 2001-10-04 | Thomas Jefferson University | Compositions and methods for identifying and targeting cancer cells |
| US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
| AU2001275376A1 (en) | 2000-06-08 | 2001-12-17 | John J Frantzen | Radially expandable stent featuring covering tip primarily for bifurcated arteryaneurysms |
| AU2001279261A1 (en) | 2000-06-23 | 2002-01-08 | John J Frantzen | Radially expandable aneurysm treatment stent |
| ES2341641T3 (es) | 2000-07-21 | 2010-06-24 | The Spineology Group, Llc | Un dispositivo de bolsa de malla porosa expansible y su uso para cirugia osea. |
| US6855154B2 (en) * | 2000-08-11 | 2005-02-15 | University Of Louisville Research Foundation, Inc. | Endovascular aneurysm treatment device and method |
| AU2001285059A1 (en) * | 2000-08-23 | 2002-03-04 | Thoratec Corporation | Coated vascular grafts and methods of use |
| MXPA03002414A (es) | 2000-09-18 | 2004-07-08 | Organogenesis Inc | Protesis con injerto de hoja plana tratada por bioingenieria y su uso. |
| US6730119B1 (en) * | 2000-10-06 | 2004-05-04 | Board Of Regents Of The University Of Texas System | Percutaneous implantation of partially covered stents in aneurysmally dilated arterial segments with subsequent embolization and obliteration of the aneurysm cavity |
| US20060135947A1 (en) | 2000-10-27 | 2006-06-22 | Pulmonx | Occlusal stent and methods for its use |
| US6589265B1 (en) | 2000-10-31 | 2003-07-08 | Endovascular Technologies, Inc. | Intrasaccular embolic device |
| US6743251B1 (en) | 2000-11-15 | 2004-06-01 | Scimed Life Systems, Inc. | Implantable devices with polymeric detachment junction |
| US6878384B2 (en) * | 2001-03-13 | 2005-04-12 | Microvention, Inc. | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| US7044958B2 (en) * | 2001-04-03 | 2006-05-16 | Medtronic Vascular, Inc. | Temporary device for capturing embolic material |
| GB2374885B (en) * | 2001-04-27 | 2003-05-14 | Smith International | Method for hardfacing roller cone drill bit legs using a D-gun hardfacing application technique |
| US6855153B2 (en) * | 2001-05-01 | 2005-02-15 | Vahid Saadat | Embolic balloon |
| US6607539B1 (en) | 2001-05-18 | 2003-08-19 | Endovascular Technologies, Inc. | Electric endovascular implant depolyment system |
| WO2002096302A1 (en) * | 2001-05-29 | 2002-12-05 | Microvention, Inc. | Method of manufacturing expansile filamentous embolization devices |
| US20020187288A1 (en) | 2001-06-11 | 2002-12-12 | Advanced Cardiovascular Systems, Inc. | Medical device formed of silicone-polyurethane |
| US6454780B1 (en) | 2001-06-21 | 2002-09-24 | Scimed Life Systems, Inc. | Aneurysm neck obstruction device |
| US20030100945A1 (en) | 2001-11-23 | 2003-05-29 | Mindguard Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
| US7011671B2 (en) * | 2001-07-18 | 2006-03-14 | Atritech, Inc. | Cardiac implant device tether system and method |
| US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
| US20030028209A1 (en) * | 2001-07-31 | 2003-02-06 | Clifford Teoh | Expandable body cavity liner device |
| US6811560B2 (en) * | 2001-09-20 | 2004-11-02 | Cordis Neurovascular, Inc. | Stent aneurysm embolization method and device |
| US20050021075A1 (en) * | 2002-12-30 | 2005-01-27 | Bonnette Michael J. | Guidewire having deployable sheathless protective filter |
| JP4429589B2 (ja) | 2001-11-15 | 2010-03-10 | コーディス・ニューロバスキュラー・インコーポレイテッド | 閉塞部材を用いる動脈瘤塞栓装置 |
| JP2003190175A (ja) * | 2001-11-15 | 2003-07-08 | Cordis Neurovascular Inc | 動脈瘤を密閉するための動脈瘤頚部プラグ |
| US20060292206A1 (en) | 2001-11-26 | 2006-12-28 | Kim Steven W | Devices and methods for treatment of vascular aneurysms |
| US20040111147A1 (en) | 2002-12-03 | 2004-06-10 | Rabkin Dmitry J. | Temporary, repositionable or retrievable intraluminal devices |
| US6752826B2 (en) | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
| US6953473B2 (en) | 2001-12-20 | 2005-10-11 | Boston Scientific Scimed, Inc. | Detachable device with electrically responsive element |
| FR2834199B1 (fr) | 2001-12-27 | 2004-10-15 | Doron Carmi | Endoprothese adaptee au milieu endoluminal |
| US20030181942A1 (en) | 2002-01-25 | 2003-09-25 | Sutton Gregg S. | Atrial appendage blood filtration systems |
| US6638257B2 (en) | 2002-03-01 | 2003-10-28 | Aga Medical Corporation | Intravascular flow restrictor |
| US7695488B2 (en) * | 2002-03-27 | 2010-04-13 | Boston Scientific Scimed, Inc. | Expandable body cavity liner device |
| US20050119684A1 (en) | 2002-07-12 | 2005-06-02 | Guterman Lee R. | Aneurysm buttress arrangement |
| US6746890B2 (en) | 2002-07-17 | 2004-06-08 | Tini Alloy Company | Three dimensional thin film devices and methods of fabrication |
| US6997904B2 (en) | 2002-12-24 | 2006-02-14 | Robert David Sculati | Viscous fluid injection system |
| US7229454B2 (en) | 2003-01-07 | 2007-06-12 | Boston Scientific Scimed, Inc. | Occlusive cinching devices and methods of use |
| JP4548338B2 (ja) | 2003-01-10 | 2010-09-22 | 株式会社カネカ | 塞栓形成用体内留置具 |
| US8377035B2 (en) * | 2003-01-17 | 2013-02-19 | Boston Scientific Scimed, Inc. | Unbalanced reinforcement members for medical device |
| US20040158311A1 (en) | 2003-02-06 | 2004-08-12 | Berhow Steven W. | Intravascular stent |
| US20040193208A1 (en) | 2003-03-27 | 2004-09-30 | Scimed Life Systems, Inc. | Radiopaque embolic protection filter membrane |
| US20040204737A1 (en) | 2003-04-11 | 2004-10-14 | Scimed Life Systems, Inc. | Embolic filter loop fabricated from composite material |
| US7597704B2 (en) | 2003-04-28 | 2009-10-06 | Atritech, Inc. | Left atrial appendage occlusion device with active expansion |
| EP1620140B1 (en) * | 2003-05-05 | 2013-10-09 | Ben-Gurion University Of The Negev Research And Development Authority | Injectable cross-linked polymeric preparations and uses thereof |
| US7122043B2 (en) | 2003-05-19 | 2006-10-17 | Stout Medical Group, L.P. | Tissue distention device and related methods for therapeutic intervention |
| US7101390B2 (en) * | 2003-05-27 | 2006-09-05 | Scimed Life Systems, Inc. | Staged deployment endograft |
| US20050053782A1 (en) * | 2003-09-04 | 2005-03-10 | Ayusman Sen | Process for forming polymeric micro and nanofibers |
| US6940209B2 (en) | 2003-09-08 | 2005-09-06 | New Scale Technologies | Ultrasonic lead screw motor |
| WO2005025630A1 (en) * | 2003-09-10 | 2005-03-24 | Cato T Laurencin | Polymeric nanofibers for tissue engineering and drug delivery |
| US7232461B2 (en) * | 2003-10-29 | 2007-06-19 | Cordis Neurovascular, Inc. | Neck covering device for an aneurysm |
| US20050149173A1 (en) * | 2003-11-10 | 2005-07-07 | Angiotech International Ag | Intravascular devices and fibrosis-inducing agents |
| WO2005055834A1 (en) * | 2003-11-20 | 2005-06-23 | Nmt Medical, Inc. | Device, with electrospun fabric, for a percutaneous transluminal procedure, and methods thereof |
| US20050133046A1 (en) | 2003-12-17 | 2005-06-23 | Becker Timothy A. | Compositions and methods for improved occlusion of vascular defects |
| US7329279B2 (en) * | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
| US7275471B2 (en) | 2003-12-29 | 2007-10-02 | Surpass Medical Ltd. | Mixed wire braided device with structural integrity |
| US20110208233A1 (en) | 2004-01-22 | 2011-08-25 | Mcguckin Jr James F | Device for preventing clot migration from left atrial appendage |
| US20060009798A1 (en) * | 2004-02-02 | 2006-01-12 | Ams Research Corporation | Methods and devices for occluding body lumens and/or enhancing tissue ingrowth |
| US8313505B2 (en) | 2004-03-19 | 2012-11-20 | Aga Medical Corporation | Device for occluding vascular defects |
| US20050228434A1 (en) | 2004-03-19 | 2005-10-13 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
| US8777974B2 (en) * | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
| US9039724B2 (en) | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
| US8398670B2 (en) | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
| US8715340B2 (en) | 2004-03-31 | 2014-05-06 | Merlin Md Pte Ltd. | Endovascular device with membrane |
| EP2856949B2 (en) * | 2004-04-08 | 2019-09-11 | Aga Medical Corporation | Flanged occlusion devices |
| US8623067B2 (en) | 2004-05-25 | 2014-01-07 | Covidien Lp | Methods and apparatus for luminal stenting |
| US20050267516A1 (en) | 2004-06-01 | 2005-12-01 | Farzad Soleimani | Embolic protection device for the prevention of stroke |
| BE1016067A3 (fr) | 2004-06-03 | 2006-02-07 | Frid Noureddine | Endoprothese luminale pour occlusion d'anevrisme et procede de fabrication d'une telle endoprothese. |
| EP1791590B1 (en) | 2004-08-25 | 2015-07-15 | Microvention, Inc. | Thermal detachment system for implantable devices |
| CA2595809A1 (en) | 2004-08-31 | 2006-03-09 | Cook Incorporated | Device for treating an aneurysm |
| USRE46662E1 (en) | 2004-09-17 | 2018-01-09 | DePuy Synthes Products, Inc. | Vascular occlusion device with an embolic mesh ribbon |
| CA2581272A1 (en) * | 2004-09-22 | 2006-05-18 | Lee R. Guterman | Cranial aneurysm treatment arrangement |
| US7201918B2 (en) * | 2004-11-16 | 2007-04-10 | Microvention, Inc. | Compositions, systems and methods for treatment of defects in blood vessels |
| US20060155323A1 (en) * | 2005-01-07 | 2006-07-13 | Porter Stephen C | Intra-aneurysm devices |
| WO2006096449A2 (en) | 2005-03-03 | 2006-09-14 | Hines Richard A | Endovascular aneurysm treatment device and delivery system |
| DE102005013547B4 (de) | 2005-03-23 | 2009-02-05 | Admedes Schuessler Gmbh | Aneurysmen-Stent und Verfahren zu seiner Herstellung |
| AU2006241123B2 (en) | 2005-04-25 | 2013-10-03 | Massachusetts Institute Of Technology | Compositions and methods for promoting hemostasis and other physiological activities |
| DE102006020687A1 (de) * | 2005-07-19 | 2007-02-08 | Aesculap Ag & Co. Kg | Stentgraft-Prothese |
| US20070021816A1 (en) * | 2005-07-21 | 2007-01-25 | The Research Foundation Of State University Of New York | Stent vascular intervention device and methods for treating aneurysms |
| US20070061006A1 (en) * | 2005-09-14 | 2007-03-15 | Nathan Desatnik | Methods of making shape memory films by chemical vapor deposition and shape memory devices made thereby |
| US8545530B2 (en) * | 2005-10-19 | 2013-10-01 | Pulsar Vascular, Inc. | Implantable aneurysm closure systems and methods |
| US20070100414A1 (en) * | 2005-11-02 | 2007-05-03 | Cardiomind, Inc. | Indirect-release electrolytic implant delivery systems |
| DE102005052628B4 (de) | 2005-11-04 | 2014-06-05 | Jenavalve Technology Inc. | Selbstexpandierendes, flexibles Drahtgeflecht mit integrierter Klappenprothese für den transvaskulären Herzklappenersatz und ein System mit einer solchen Vorrichtung und einem Einführkatheter |
| US8100938B2 (en) * | 2005-11-14 | 2012-01-24 | Occlutech Holding Ag | Occlusion device for occluding an atrial auricula and method for producing same |
| US8455088B2 (en) | 2005-12-23 | 2013-06-04 | Boston Scientific Scimed, Inc. | Spun nanofiber, medical devices, and methods |
| US7744652B2 (en) | 2006-01-23 | 2010-06-29 | Hesham Morsi | Aneurysm sealing device |
| GB0603685D0 (en) | 2006-02-23 | 2006-04-05 | Angiomed Ag | Vascular prosthesis for aneurysms, set of vascular prostheses, method for manufacturing a vascular prosthesis and method for inserting a vascular prosthesis |
| DE102006013770A1 (de) | 2006-03-24 | 2007-09-27 | Occlutech Gmbh | Occlusionsinstrument und Verfahren zu dessen Herstellung |
| WO2007134266A2 (en) | 2006-05-12 | 2007-11-22 | Electroformed Stents, Inc. | Exclusion device and system for delivery |
| US20080033341A1 (en) * | 2006-08-04 | 2008-02-07 | Bay Holdings Ltd. | Methods and devices for reducing or blocking blood flow to a selected blood vessel or part thereof |
| EP2056747A2 (en) | 2006-08-17 | 2009-05-13 | NFOCUS Neuromedical Inc. | Isolation devices for the treatment of aneurysms |
| GB0616738D0 (en) * | 2006-08-23 | 2006-10-04 | Evexar Medical Ltd | Improvements in and relating to medical devices |
| EP1923019B1 (en) * | 2006-11-20 | 2010-10-20 | SeptRx, Inc. | Device for preventing the undesired passage of emboli from a venous blood pool to an arterial blood pool |
| US8574258B2 (en) * | 2007-02-16 | 2013-11-05 | Reverse Medical Corporation | Occlusion device and method of use |
| US7573382B2 (en) | 2007-04-02 | 2009-08-11 | General Electric Company | System and method to manage movement of assets |
| EP2460476B1 (de) | 2007-04-16 | 2020-11-25 | Occlutech Holding AG | Occluder zum Verschließen eines Herzohres und Herstellungsverfahren dafür |
| WO2008134468A1 (en) * | 2007-04-27 | 2008-11-06 | Wisconsin Alumni Research Foundation | Bioactive and biocompatible polyurethane-butanediol-glycosaminoglycan salt copolymers |
| US20110022149A1 (en) | 2007-06-04 | 2011-01-27 | Cox Brian J | Methods and devices for treatment of vascular defects |
| US8361138B2 (en) * | 2007-07-25 | 2013-01-29 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
| WO2009036219A1 (en) | 2007-09-11 | 2009-03-19 | Nfocus Neuromedical Inc. | Aneurysm cover device for embolic delivery and retention |
| US20090082803A1 (en) * | 2007-09-26 | 2009-03-26 | Aga Medical Corporation | Braided vascular devices having no end clamps |
| US9414842B2 (en) | 2007-10-12 | 2016-08-16 | St. Jude Medical, Cardiology Division, Inc. | Multi-component vascular device |
| JP5160878B2 (ja) | 2007-12-21 | 2013-03-13 | 浜松ホトニクス株式会社 | 試料同定装置および試料同定方法 |
| EP2234562B1 (en) | 2007-12-21 | 2019-02-27 | MicroVention, Inc. | A system and method of detecting implant detachment |
| US20090227976A1 (en) | 2008-03-05 | 2009-09-10 | Calabria Marie F | Multiple biocompatible polymeric strand aneurysm embolization system and method |
| WO2009121006A1 (en) | 2008-03-27 | 2009-10-01 | Nfocus Neuromedical, Inc. | Friction-release distal latch implant delivery system and components |
| US7806919B2 (en) * | 2008-04-01 | 2010-10-05 | Medtronic Vascular, Inc. | Double-walled stent system |
| JP5610542B2 (ja) * | 2008-04-21 | 2014-10-22 | コヴィディエン リミテッド パートナーシップ | ブレードボール塞栓装置および送達システム |
| US20090318948A1 (en) | 2008-04-22 | 2009-12-24 | Coherex Medical, Inc. | Device, system and method for aneurysm embolization |
| JP2011519300A (ja) | 2008-05-01 | 2011-07-07 | アニュクローズ エルエルシー | 動脈瘤閉塞装置 |
| WO2009135166A2 (en) | 2008-05-02 | 2009-11-05 | Sequent Medical Inc. | Filamentary devices for treatment of vascular defects |
| US8041095B2 (en) | 2008-06-11 | 2011-10-18 | Siemens Aktiengesellschaft | Method and apparatus for pretreatment planning of endovascular coil placement |
| US9351715B2 (en) * | 2008-07-24 | 2016-05-31 | St. Jude Medical, Cardiology Division, Inc. | Multi-layered medical device for treating a target site and associated method |
| US20100069948A1 (en) * | 2008-09-12 | 2010-03-18 | Micrus Endovascular Corporation | Self-expandable aneurysm filling device, system and method of placement |
| US9427304B2 (en) * | 2008-10-27 | 2016-08-30 | St. Jude Medical, Cardiology Division, Inc. | Multi-layer device with gap for treating a target site and associated method |
| US20120071911A1 (en) * | 2009-05-20 | 2012-03-22 | University Of Miami | Spherical helix embolic coils for the treatment of cerebral aneurysms |
| US20110054515A1 (en) * | 2009-08-25 | 2011-03-03 | John Bridgeman | Device and method for occluding the left atrial appendage |
| JP2013509914A (ja) | 2009-11-05 | 2013-03-21 | シークエント メディカル， インコーポレイテッド | 複数層フィラメント状デバイスまたは血管障害処置 |
| WO2011057277A2 (en) * | 2009-11-09 | 2011-05-12 | Nfocus Neuromedical, Inc. | Braid ball embolic device features |
| US8771289B2 (en) | 2009-12-21 | 2014-07-08 | Acist Medical Systems, Inc. | Thrombus removal device and system |
| EP2613735B1 (en) | 2010-09-10 | 2018-05-09 | Covidien LP | Devices for the treatment of vascular defects |
| US9351859B2 (en) | 2010-12-06 | 2016-05-31 | Covidien Lp | Vascular remodeling device |
| US20120283768A1 (en) | 2011-05-05 | 2012-11-08 | Sequent Medical Inc. | Method and apparatus for the treatment of large and giant vascular defects |
| US8261648B1 (en) * | 2011-10-17 | 2012-09-11 | Sequent Medical Inc. | Braiding mechanism and methods of use |
| US9211132B2 (en) | 2012-06-27 | 2015-12-15 | MicoVention, Inc. | Obstruction removal system |
-
2010
- 2010-11-04 JP JP2012537226A patent/JP2013509914A/ja active Pending
- 2010-11-04 CA CA2778639A patent/CA2778639A1/en not_active Abandoned
- 2010-11-04 WO PCT/US2010/055494 patent/WO2011057002A2/en not_active Ceased
- 2010-11-04 EP EP10829110.5A patent/EP2496299B1/en active Active
- 2010-11-04 AU AU2010315106A patent/AU2010315106A1/en not_active Abandoned
- 2010-11-04 CN CN2010800543559A patent/CN102639181A/zh active Pending
- 2010-11-04 BR BR112012010758A patent/BR112012010758A2/pt not_active IP Right Cessation
- 2010-11-04 US US12/939,901 patent/US20110152993A1/en not_active Abandoned
-
2012
- 2012-04-04 US US13/439,754 patent/US9918720B2/en active Active
-
2016
- 2016-04-08 US US15/094,084 patent/US10238393B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2496299B1 (en) | 2019-03-06 |
| WO2011057002A3 (en) | 2011-09-29 |
| JP2013509914A (ja) | 2013-03-21 |
| US20160249937A1 (en) | 2016-09-01 |
| US20120197283A1 (en) | 2012-08-02 |
| EP2496299A2 (en) | 2012-09-12 |
| WO2011057002A2 (en) | 2011-05-12 |
| CA2778639A1 (en) | 2011-05-12 |
| EP2496299A4 (en) | 2014-08-27 |
| US9918720B2 (en) | 2018-03-20 |
| CN102639181A (zh) | 2012-08-15 |
| BR112012010758A2 (pt) | 2019-09-24 |
| US20110152993A1 (en) | 2011-06-23 |
| US10238393B2 (en) | 2019-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12318091B2 (en) | Filamentary devices for treatment of vascular defects | |
| US20250025181A1 (en) | Filamentary devices for treatment of vascular defects | |
| US11723667B2 (en) | Filamentary devices for treatment of vascular defects | |
| US10238393B2 (en) | Multiple layer filamentary devices for treatment of vascular defects | |
| US20120283768A1 (en) | Method and apparatus for the treatment of large and giant vascular defects |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |